SOURCE: Elsevier Business Intelligence
SAN FRANCISCO, CA--(Marketwire - Jul 31, 2012) - Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, has announced that its 'Investment in Innovation (IN3) Medical Device 360° Summit-San Francisco' strategic partnering and investment conference on October 15-17, 2012, will bring together a diverse and insightful group of key medtech thought leaders and investors -- from Corporate Business Development, Venture Capital and Strategic Investment, Start-Up Entrepreneurs and Industry Pioneers -- to candidly discuss the critical issues impacting all players in the evolving device space. The two-day event will take place in the hub of device investment and innovation in the Bay Area, at the historic InterContinental Mark Hopkins San Francisco on Nob Hill.
Summit-San Francisco will feature presentations by more than 30 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership. Confirmed presenters to date include: Endoscape, HistoSonics, Impeto Medical, MGI Medical, Micro Interventional Devices, Monteris Medical, Nordocs, OncoSec Medical, Orthorebirth, Poiesis Medical, Soft Tissue Regeneration, Suspension Orthopaedic Solutions, Therapeutic Monitoring Systems and VertiFlex.
In addition to the timely opening presentation -- "The 2012 Elections: Impact on FDA, Healthcare Reform and the Future of Medical Technology Innovation" by Mark Leahey, President and CEO, Medical Device Manufacturers Association (MDMA) -- Summit-San Francisco also will feature a Fireside Chat by Thomas J. Fogarty, internationally recognized cardiovascular surgeon, inventor and entrepreneur. Additionally, a special evening presentation will be given by Don Urbanowicz, President, Urbanowicz Consulting: "Top 10 Value Drivers Strategics Look for in Pre-Revenue Start-Ups." Insightful panel topics will include: "Strategics on Deal Priorities: Driving Growth through Different Structures"; "Medtech Investing: What Types of Deals VCs Prefer"; and, "Medtech Investing: Where Is the Capital Going?" Investors confirmed to participate to date include Aberdare Ventures (Sami Hamade, Partner); Advanced Technology Ventures (Mike Carusi, General Partner); edbi (Heng-Tong Choo, SVP, Investments); Medtronic (Erich Wolff, Dir. Corporate Dev.); Psilos Group (Lisa Suennen, Co-Founder, Managing Member); Stryker (Eric Elam, Dir. Bus Dev.) and Versant Ventures (Charles Warden, Managing Director), among many others.
Emerging medtech companies that would like to apply to present in San Francisco should contact Kayleen Kell at 949-797-7142, or email email@example.com. In addition to all of the customary conference benefits, presenting company CEOs have the opportunity to be interviewed on camera, at no charge, for a 3-minute exclusive video in which they may discuss their company and technology. These interviews will be featured post-conference at www.in3tv.com. All of the one-on-one interviews with presenting-company CEOs will take place at, and during, the Summit-San Francisco conference and be organized by medtech PR/IR expert Ronald Trahan, President of Ronald Trahan Associates, Inc. Videotaping will take place on a 'walk-in' basis on only one day of the event: Tuesday, October 16th.
This two-day Summit conference will benefit anyone with a stake in the medical device sector: start-ups seeking investment or strategic partnership, investment firms, VCs, mid-size and large device manufacturers, and service providers. Partnering software will be available to all registered attendees prior to the conference so that one-on-one on-site meetings can be pre-arranged.
Event co-sponsors include Ronald Trahan Associates Inc., Medmarc with The Hartford and Biomedic-Insure, Knobbe Martens, Emerson Consultants, MassMedic Angels, Neocure Group, Pharma Connections Worldwide, Life Science Intelligence, Current Partnering and marketwire. Visit www.IN3Summit.com for full conference and registration details.
About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.